Atlas Trials

Satisfaction of HIV-infected Patients Treated With Cabotegravir-rilpivirine Injectable Dual Therapy

Clinical trial NCT05697289 · UNKNOWN

Trial details

NCT number
NCT05697289
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Study type
OBSERVATIONAL
HIV Infections
Start date
2023-01-01
Primary completion
2023-06-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.